Horizon Therapeutics Public Ltd Co — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/07e7acf4-2cf8-47c3-94cd-c692c617b51c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $3.6B | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005337 |
| FY 2021 | $3.2B | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-007863 |
| FY 2020 | $2.2B | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007818 |
| FY 2019 | $1.3B | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006575 |
| FY 2018 | $1.2B | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004667 |
| FY 2017 | $1.1B | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004667 |
| FY 2016 | $981.1M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004667 |
| FY 2015 | $757.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013652 |
| FY 2014 | $297.0M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-067257 |
| FY 2013 | $74.0M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-096677 |
| FY 2012 | $18.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-096677 |
| FY 2011 | $6.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-129945 |
| FY 2010 | $2.4M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-129945 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Horizon Therapeutics Public Ltd Co — all facts · Net Income · Operating Income